Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.
Sign Up to like & getrecommendations! Published in 2018 at "European urology"
DOI: 10.1016/j.eururo.2017.03.036
Abstract: BACKGROUND Risk of prostate cancer-specific mortality (PCSM) is highly variable for men with adverse pathologic features at radical prostatectomy (RP); a majority will die of other causes. Accurately stratifying PCSM risk can improve therapy decisions.… read more here.
Keywords: prostate; risk; pathologic features; men adverse ... See more keywords
The impact of race on adverse pathologic features at the time of radical prostatectomy in men with prostate cancer and implications for adjuvant radiotherapy.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.6_suppl.75
Abstract: 75Background: Patients with adverse pathologic features (≥pT3 disease or positive margins) at the time of radical prostatectomy (RP) have higher biochemical recurrence (BR). Adjuvant radiotherapy (ART) reduces BR, but has potential toxicities. Also, studies suggest… read more here.
Keywords: time radical; pathologic features; cancer; race ... See more keywords
The effect of time from biopsy to radical prostatectomy on adverse pathologic outcomes
Sign Up to like & getrecommendations! Published in 2019 at "Research and Reports in Urology"
DOI: 10.2147/rru.s187950
Abstract: Objective To assess the impact of time between prostate cancer diagnosis on biopsy and definitive intervention with radical prostatectomy (RP) in regard to adverse pathologic outcomes using a large multi-surgeon database. Materials and methods We… read more here.
Keywords: time; biopsy; adverse pathologic; pathologic outcomes ... See more keywords